GobyMeds Review

What GobyMeds charges

• Sermorelin: $199/mo — for 1 month, printed whole on both the sermorelin page and the pricing page; the '$133+/mo' badge above it is the 3-month total divided and is not this figure
• Sermorelin: $199/mo — for 1 month, for the line the seller calls Sermorelin Oral Tablets; the same figure appears on the sermorelin page and the pricing page
• NAD+: $199/mo — for 1 month, the only NAD+ format whose one-month figure is identical on both the NAD+ page and the pricing page
• NAD+: $349 — prepaid total for a stated 3 months — the only NAD+ injection figure the seller's two pages agree on, because its one-month figure is printed as $179 on the NAD+ page and as $199 on the pricing page

The partners are named, with contact details

The safety-information page lists four dispensing pharmacy partners under that heading, each with a phone number, an email address and a domain. A reader can look every one of them up.

Under a second heading it names the medical practitioner partner, and the telemedicine statement names a second medical group alongside it. Those are the entities that furnish the care, and the seller says plainly in its terms that it does not itself practise medicine, prescribe, dispense or operate a pharmacy.

That distinction is worth keeping straight. A named medical group is not a named prescriber, and a list of pharmacy partners is not an answer to which one will fill a given order — the seller says elsewhere that a patient may not be able to choose.

Even with those caveats, this is a fuller answer than a licence class or an accreditation body, and it is published on a page a reader can reach without an account.

Every headline rate on the peptide pages is a division

Both peptide pages lead with a per-month figure in the hero and repeat it as a badge on each format card. Underneath each badge, the same card prints the figures the seller actually charges: one for a single month and one for a multi-month bundle.

Divide the bundle by its length and the badge is what comes out, to the cent, on the injectable NAD+ line, on the injectable sermorelin line, on the sermorelin troche and on the sermorelin film-strip. The pricing page repeats the same divided figure for the NAD+ bundle.

A divided rate is not a rate anyone is charged. Nobody pays it monthly; it is a bundle total wearing a monthly label, and a comparison built on it would rank this seller against others on a number none of its customers ever sees on a statement.

So this row stores the whole figures printed beneath the badges. The seller deserves some credit for printing them at all — a badge with no arithmetic beneath it would have been unverifiable.

Two pages, one line, two different one-month prices

The NAD+ page and the pricing page describe the same injectable line and print different one-month figures for it. They agree exactly on the multi-month figure for that line.

Both numbers are published, both are on the seller's own site, and only one of them can be the price. There is no dated note, no promotion banner and no strike-through on either page to say which is current, so there is no basis in the pages themselves for choosing.

Recording either one would be recording a guess. This row therefore stores the multi-month figure the two pages agree on, qualified as the prepaid total it is, and stores the conflict in the row so a later reader sees the reason rather than inheriting the choice.

The seller's other lines do not have this problem. The nasal spray and both sermorelin formats carry the same one-month figure on both pages, and those are stored as monthly rates.

Coverage, labs and the things the pages leave out

The home page's trust bar advertises the whole country, unqualified, in the seller's own words about its own care. The telemedicine statement adds the standard qualification that services are available only where the applicable provider is licensed and only while a patient is physically located there.

This site records the advertised claim and notes the qualification beside it, because the two sit in different documents and a reader will meet the first long before the second.

On laboratory work the seller is direct: each of its testosterone lines carries a sentence saying lab work costs extra. Nothing comparable appears on the peptide pages, and no lab is included with either peptide line.

Neither peptide page states a dose or a concentration, so the formats are distinguished by delivery method rather than by quantity, and no corporate entity is published behind the brand — only a street address and a phone number in the footer.

How we verified this

• Rendered every page in a browser and read the figures from the rendered document rather than from served markup.
• Took the three page paths from the seller's own link list and confirmed each against its sitemap before reading anything from them.
• Fired a nonsense path at the same depth in the same run and confirmed it renders the seller's own not-found document rather than a product page, so an absence here is an absence and not a template.
• Compared each headline per-month badge against the whole figures printed on the same card, divided the multi-month figure by its stated length, and confirmed the badge is that quotient on four separate lines.
• Recorded only figures the seller prints whole, and stored the divided badges nowhere.
• Read the same NAD+ line on both the product page and the pricing page, found two different one-month figures and one agreed multi-month figure, and stored the agreed figure with the conflict written into the row.
• Confirmed the nasal spray and both sermorelin formats carry the same one-month figure on both pages before storing either as a monthly rate.
• Read the safety-information page for the pharmacy partner list and the telemedicine statement and terms for the medical groups, and confirmed the terms disclaim operating a pharmacy or practising medicine.
• Read the trust bar for the coverage claim and the telemedicine statement for the qualification attached to it, and recorded both.
• Read the pricing page's testosterone lines for the explicit statement that lab work costs extra, and confirmed no lab inclusion appears on either peptide line.
• Searched the published federal warning-letter record under two spellings of the brand, having first proved the parser on a company whose letter is known to be in that record and on a nonsense term in the same run, and found no letter to this seller.